EDITASMEDICINE.COM KEYWORD DENSITY CHECKER

Total words: 1136 | 2-word phrases: 292 | 3-word phrases: 325 | 4-word phrases: 346

PAGE INFO

Title Try to keep the title under 60 characters (15 characters)
Editas Medicine
Description Try to keep the meta description between 50 - 160 characters (122 characters)
Editas Medicine is a leading gene editing company focused on developing CRISPR medicines for people with serious diseases.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (4 characters)
Home

ONE WORD PHRASES 173 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1editas2615.03%
2and2413.87%
3medicine2313.29%
4the2011.56%
5to148.09%
6of137.51%
7we126.94%
8our126.94%
9for105.78%
10in95.20%

TWO WORD PHRASES 292 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1editas medicine227.53%
2announces second62.05%
3quarter 202462.05%
4we are62.05%
5second quarter62.05%
62024 results62.05%
7at editas51.71%
8get in41.37%
9in touch41.37%
10medicines for41.37%
11medicine announces41.37%
12more about41.37%
13learn more41.37%
14gene editing41.37%
15ruby trial31.03%
16for people31.03%
17people living31.03%
18from the31.03%
19the ruby31.03%
20in 1831.03%

THREE WORD PHRASES 325 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1quarter 2024 results61.85%
2second quarter 202461.85%
3announces second quarter61.85%
4at editas medicine51.54%
5learn more about41.23%
6get in touch41.23%
7medicine announces second41.23%
82024 results and30.92%
9editas medicine announces30.92%
10newsroom aug 730.92%
11sickle cell disease30.92%
12cell disease presented30.92%
13disease presented at30.92%
14presented at the30.92%
15and business updates30.92%
16at the european30.92%
17the european hematology30.92%
18we’re working on30.92%
19around the world30.92%
20people living with30.92%
21eha annual congress30.92%
22for people living30.92%
23medicines for people30.92%
24of renicel in30.92%
25results and business30.92%
26trial of renicel30.92%
27renicel in 1830.92%
28update jun 1430.92%
29ruby trial of30.92%
30the ruby trial30.92%

FOUR WORD PHRASES 346 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1second quarter 2024 results61.73%
2announces second quarter 202461.73%
3medicine announces second quarter41.16%
4trial of renicel in30.87%
5sickle cell disease presented30.87%
6medicines for people living30.87%
7of renicel in 1830.87%
8at the european hematology30.87%
9presented at the european30.87%
10disease presented at the30.87%
1114 editas medicine reports30.87%
12jun 14 editas medicine30.87%
13update jun 14 editas30.87%
14corporate update jun 1430.87%
15and corporate update jun30.87%
16cell disease presented at30.87%
17for people living with30.87%
18efficacy data from the30.87%
19newsroom aug 7 editas30.87%
20ruby trial of renicel30.87%
21results and business updates30.87%
222024 results and business30.87%
23quarter 2024 results and30.87%
24editas medicine announces second30.87%
25the ruby trial of30.87%
26from the ruby trial30.87%
27data from the ruby30.87%
28medicine the work we20.58%
29the work we do20.58%
30remove and replace dna20.58%
31more about our commitment20.58%
32learn more about our20.58%
33learn more about editas20.58%
34world learn more about20.58%
35the world learn more20.58%
36around the world learn20.58%
37patients around the world20.58%
38people living with serious20.58%
39and replace dna in20.58%
40business updates jul 3120.58%

EXTERNAL LINKS

# URL Whois Check
1https://www.linkedin.com/company/editas-medicine/ Whoislinkedin.com
2 https://www.linkedin.com/company/editas-medicine/ Whoislinkedin.com
3 https://www.linkedin.com/company/editas-medicine/ Whoislinkedin.com
4 https://www.linkedin.com/company/editas-medicine/ Whoislinkedin.com